Sociedad Española de Terapia Génica y Celular
  • Home
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
Home

This week in gene and cell therapy - 31 August 2018

Gene and cell therapy headlines 27 - 31 August


MeiraGTx' AAV-CNGA3 gene therapy for achromatopsia granted rare pediatric disease designation

CAR-T news: Novartis' Kymriah and Gilead's Yescarta approved by EMA, but UK's National Health Service rejects Yescarta as too expensive

bluebird bio and Gritstone Oncoloy announce partnership to develop cell therapy

Gene therapy effective and safe in rat model of epilepsy

Adverum's ADVM-022 gene therapy for macular degeneration granted investigational new drug status

Exon skipping gene therapy for Duchenne muscular dystrophy effective in dogs



 

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2023 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us